Vascular function and cardiovascular risk factors in women with severe flushing

Clinical Endocrinology

Volumn 74, Issue 1, 2011, Pages 97-103

  Sassarini, J ^a   Fox, H ^a   Ferrell, W ^a   Sattar, N ^a   Lumsden, M A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; NITROPRUSSIDE SODIUM; VASOACTIVE AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ELECTRIC CURRENT; ENDOTHELIUM; FEMALE; HOT FLUSH; HUMAN; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; POSTMENOPAUSE; PRIORITY JOURNAL;

ACETYLCHOLINE; AGED; APOLIPOPROTEIN A-I; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; ENDOTHELIUM, VASCULAR; FEMALE; HOT FLASHES; HUMANS; IONTOPHORESIS; MIDDLE AGED; NITROPRUSSIDE; RISK FACTORS; VASODILATOR AGENTS;

EID: 78650387331     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03921.x     Document Type: Article

References (29)

1. Freeman, E.W., &, Sherif, K., (2007) Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric, 10, 197-214.
2. Keating, N.L., Cleary, P.D., Rossi, A.S., et al. (1999) Use of hormone replacement therapy by postmenopausal women in the United States. Annals of Internal Medicine, 130, 545-553.
3. Kronenberg, F., (1994) Hot flashes: phenomenology, quality of life, and search for treatment options. Experimental Gerontology, 29, 319-336.
4. Brockie, J.A., Barlow, D.H., &, Rees, M.C.P., (1991) Menopausal flush symptomatology and sustained reflex vasoconstriction. Human Reproduction, 6, 472-474.
5. Ginsburg, J., Hardiman, P., &, O'Reilly, B., (1989) Peripheral blood flow in menopausal women who have hot flushes and in those who do not. British Medical Journal, 298, 1488-1490.
6. Sattar, N., Wannamethee, S.G., &, Forouhi, N.G., (2008) Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia, 51, 926-940.
7. Ramsay, J.E., Ferrell, W.R., Greer, I.A., et al. (2002) Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. Journal of Cardiovascular Pharmacology, 39, 9-17.
8. Nilsson, G.E., Tenland, T., &, Oberg, P.A., (1980) A new instrument for continuous measurement of tissue blood flow by light beating spectroscopy. IEEE Transactions on Biomedical Engineering, 27, 597-604.
9. Kubli, S., Waeber, B., Dalle-Ave, A., et al. (2000) Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. Journal of Cardiovascular Pharmacology, 36, 640-648.
10. Morris, S.J., &, Shore, A.C., (1996) Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. Journal of Physiology, 496, 531-542.
11. Wardell, K., Jakobsson, A., &, Nilsson, G.E., (1993) Laser Doppler perfusion imaging by dynamic light scattering. IEEE Transactions on Biomedical Engineering, 40, 309-316.
12. Ferrell, W.R., Ramsay, J.E., Brooks, N., et al. (2002) Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. Journal of Vascular Research, 39, 447-455.
13. Khan, F., Davidson, N.C., Littelford, R.C., et al. (1997) Cutaneous vascular responses to acetylcholine are mediated by a prostacyclin-dependent mechanism in man. Vascular medicine, 2, 82-86.
14. Noon, J., Walker, B., Hand, M., et al. (1998) Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. British Journal of Clinical Pharmacology, 45, 545-550.
15. Caballero, A.E., Arora, S., Saouaf, R., et al. (1999) Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes, 48, 1856-1862.
16. Ramsay, J.E., Ferrell, W.R., Crawford, L., et al. (2002) Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. Journal of Clinical Endocrinology and Metabolism, 87, 4231-4237.
17. Khan, F., Litchfield, S.J., Stonebridge, P.A., et al. (1999) Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease. Vascular medicine, 4, 233-238.
18. Martin, B.-J., &, Anderson, T.J., (2009) Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction. Canadian Journal of Cardiology, 25 (Suppl A), 15A-20A.
19. Thurston, R.C., Sutton-Tyrrell, K., Everson- Rose, S.A., et al. (2008) Hot flashes and subclinical cardiovascular disease: findings from the study of Women's Health Across the Nation Heart Study. Circulation, 118, 1234-1240.
20. The Emerging Risk Factors Collaboration. (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 302, 1993-2000.
21. Lerman, A., &, Zeiher, A.M., (2005) Endothelial function: cardiac events. Circulation, 111, 363-368.
22. Huang, P.L., Huang, Z., Mashimo, H., et al. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature [ ], 377, 239-242.
23. Bechlioulis, A., Kalantaridou, S.N., Naka, K.K., et al. (2010) Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. Journal of Clinical Endocrinology and Metabolism, 95, 1199-1206.
24. Gambacciani, M., &, Pepe, A., (2009) Vasomotor symptoms and cardiovascular risk. Climacteric, 12, 32-35.
25. Freedman, R.R., (1995) Pathophysiology and treatment of menopausal hot flashes. Seminars in Reproductive Medicine, 23, 117-125.
26. Modena, M.G., Bonetti, L., Coppi, F., et al. (2002) Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. Journal of the American College of Cardiology, 40, 505-510.
27. Leal, M, Diaz, J, Serrano, E, et al. (2000) Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstetrics & Gynecology, 95 (6, Part 1): 804-809.
28. Andrikoula, M., Hardiman, P., &, Prelevic, G., (2009) Menopausal hot lfush: is it only a nuisance or also a marker of cardiovascular disease risk? Gynecological Endocrinology, 25, 450-454.
29. Lobo, R.A., (2004) Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials [Editorial]. Archives of Internal Medicine, 164, 482-484.